The table below shows RHYTHM PHARMACEUTICALS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$115.67M
-$113.88M
-$136.16M
-$173.43M
-$146.00M
-$121.98M
Capital expenditure
$953.00K
$0.00
$47.00K
$281.00K
$434.00K
$214.00K
Investing cash flow
-$137.15M
-$48.17M
-$5.67M
$28.03M
-$62.16M
$158.53M
Dividends paid
-
-
-
-
RYTM operating cash flow (10-K history)
RHYTHM PHARMACEUTICALS, INC. reported operating cash flow of -$115.67M for fiscal year 2025. That is down 1.6% from -$113.88M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$23.22M (FY 2016) to -$115.67M. Figures come from the company's audited annual reports as filed with the SEC.
